Literature DB >> 11531897

The lack of vasoconstrictor effect of the pineal hormone melatonin in an animal model predictive of antimigraine activity.

B Tom1, P De Vries, J P Heiligers, E W Willems, E Scalbert, P Delagrange, P R Saxena.   

Abstract

The pineal hormone, melatonin, has been implicated in the pathophysiology of migraine and several studies have demonstrated its vasoconstrictor properties. In the present study, systemic and carotid haemodynamic effects of melatonin, administered directly into the carotid artery, were investigated in anaesthetized pigs. Ten-minute intracarotid infusions of melatonin (1, 10 and 100 microg kg(-1) min(-1)) produced slight decreases in blood pressure and total carotid and arteriovenous anastomotic blood flows, but nutrient blood flow was not affected. The decrease in carotid blood flow was entirely caused by the hypotension, since no changes in vascular conductance values were observed. It is concluded that melatonin itself is not capable of producing vasoconstriction in the cranial circulation of anaesthetized pigs. Thus, it appears that melatonin has no anti-migraine potential via a vasoconstrictor mechanism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531897     DOI: 10.1046/j.1468-2982.2001.00215.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  2 in total

Review 1.  Role of melatonin in the pathophysiology of migraine: implications for treatment.

Authors:  Barbara Vogler; Alan M Rapoport; Stewart J Tepper; Fred Sheftell; Marcelo E Bigal
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 2.  Melatonin for cognitive impairment.

Authors:  S L Jansen; D A Forbes; V Duncan; D G Morgan
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.